A meta-analysis of biological variation in blood-based therapy as a precursor to bio-manufacturing
Currently cellular therapies, such as hematopoietic stem cell transplantation (HSCT), are produced at a small scale on a case-by-case basis, usually in a clinical or near-clinical setting. Meeting the demand for future cellular therapies will require a robust and scalable manufacturing process that...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Default Article |
| Published: |
2016
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2134/21083 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|